论文部分内容阅读
目的探讨锥颅联合尿激酶灌注治疗颅内出血的临床效果。方法采用术前CT定位,手术室锥颅,术后持续血肿引流,必要时灌注尿激酶的治疗方法。结果 302例患者,术后6h内复查头颅CT,其中291例(96.4%)穿刺准确,锥颅针位于血肿腔内,11例因锥颅针偏移行二次锥颅。引流2~7d后血肿量减少>70%的270例(89.4%),减少50%~70%的26例(8.6%),2例(0.7%)患者术后死亡,4例(1.3%)患者术后出血增多,改行开颅手术。结论对于生命征稳定,未发生脑疝的各种颅内出血患者,锥颅手术简单易行、恢复快、并发症少。
Objective To investigate the clinical effect of skull combined with urokinase in the treatment of intracranial hemorrhage. Methods Preoperative CT location, operating room skull, continuous hematoma drainage, if necessary, infusion of urokinase treatment. Results In 302 patients, head CT was reviewed within 6 hours after surgery. Among them, 291 cases (96.4%) were punctured correctly, the traumatic cone was located in the hematoma cavity, and 11 cases were caused by the cone skull. 270 cases (89.4%) had hematoma reduction> 70%, 26 cases (8.6%) reduced by 50% ~ 70% and 2 cases (0.7%) died after drainage 2 ~ Patients with increased bleeding, craniotomy switch. Conclusion For patients with stable intrauterine life and no intracerebral hemorrhage, skull craniotomy is simple and easy to operate, with quick recovery and few complications.